Skip to main content
. 2014 Nov 14;46(2):487–496. doi: 10.3892/ijo.2014.2752

Table IV.

miR-23b/27b common target genes highly expressed in bladder cancer.

Clinical BCs

Change P-value Entrez gene ID Symbol Description
19.55 4.67E-05 7849 PAX8 Paired box 8
6.79 1.14E-04 1021 CDK6 Cyclin-dependent kinase 6
5.98 1.64E-04 1956 EGFR Epidermal growth factor receptor
5.00 2.65E-04 2034 EPAS1 Endothelial PAS domain protein 1
4.74 1.21E-04 208 AKT2 v-akt murine thymoma viral oncogene homolog 2
4.60 5.91E-04 2246 FGF1 Fibroblast growth factor 1 (acidic)
4.20 8.23E-04 861 RUNX1 Runt-related transcription factor 1
3.96 3.16E-03 2250 FGF5 Fibroblast growth factor 5
3.91 3.75E-04 7170 TPM3 Tropomyosin 3
3.75 4.46E-04 4089 SMAD4 SMAD family member 4
3.75 5.59E-04 3918 LAMC2 Laminin, γ 2
3.42 7.80E-05 862 RUNX1T1 Runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
3.31 6.45E-05 5979 RET Ret proto-oncogene
3.09 1.75E-02 4286 MITF Microphthalmia-associated transcription factor
2.87 8.69E-04 4233 c-Met Met proto-oncogene
2.83 1.15E-02 2259 FGF14 Fibroblast growth factor 14
2.83 1.14E-04 3845 KRAS Kirsten rat sarcoma viral oncogene homolog
2.68 2.32E-02 7188 TRAF5 TNF receptor-associated factor 5
2.63 2.73E-03 2932 GSK3B Glycogen synthase kinase 3 β
2.60 1.82E-03 5594 MAPK1 Mitogen-activated protein kinase 1
2.40 1.48E-03 4193 MDM2 MDM2 oncogene, E3 ubiquitin protein ligase
2.37 1.40E-03 5579 PRKCB Protein kinase C, β